Overview


According to FutureWise analysis the market for Fecal Occult Testing in 2023 is US$ 1.64 billion, and is expected to reach US$ 2.22 billion by 2031 at a CAGR of 5.7%.

A test for fecal occult blood looks for blood in your poop, or faeces. A small sample of stool is collected and sent to a doctor or laboratory for testing in a special collection tube or on a special card. Blood in the stool could indicate colorectal cancer or other issues like polyps, ulcers, or haemorrhoids. There are two types of faecal occult blood tests: guaiac faecal occult blood test and immunochemical faecal occult blood test. Guaiac faecal occult blood test looks for blood in the stool using a chemical called guaiac. An antibody is used in the immunochemical faecal occult blood test to detect blood in the stool. Also known as FOBT.

Fecal occult testing is currently being encouraged because of the rising awareness of early screening because it allows for quick medical decisions, offers efficient healthcare, improves the quality of life, and lowers mortality rates. One of the significant factors driving the market expansion is the growing emphasis on integrated health services for better patient experiences and health outcomes, which is occurring at the same time as a growing preference for point-of-care diagnostics (POCD). In addition, as the chance of developing diseases rises with aging, the market is growing faster due to the growing geriatric population. As a result, multiple FOBT screening programs for senior citizens are being implemented by regulatory bodies in various nations. Furthermore, the market is expanding as a result of the increased use of minimally invasive (MI) procedures. Alongside this, immunochemical fecal occult blood tests (iFOBTs or FITs) are gaining interest as they are straightforward to use and clinically more sensitive to malignancies and advanced adenomas. During the forecast period, it is estimated that the widespread availability of FOBT devices at online retail stores will positively affect market growth.

FutureWise Market Research has published a report that provides an insightful analysis of fecal occult market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the fecal occult market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Quidel Corporation
  • EIKEN CHEMICAL CO., LTD.
  • Epigenomics AG
  • Beckman Coulter, Inc.
  • Abbott Laboratories
  • Biohit Oyj.
  • Polymedco CDP, LLC
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • EDP Biotech

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent development for Fecal Occult Testing Market:

  • Eiken Chemical Co., Ltd. launched the fully automated faecal immunochemical test/Fecal Calprotectin Analyzer "OC-SENSOR Ceres" in November 2022. This has aided the company in establishing its product on a global scale.

A condition of the digestive system that affects the colon or rectum is colorectal cancer. Contrary to other malignancies, colorectal cancer may frequently be prevented with screening and is treated when found early. Most incidences of colorectal cancer affect persons 45 and older. The disease is increasingly impacting younger people due to unhealthy lifestyles and smoking habits. Blood in or on the stool, odd bowel movements including constipation or diarrhoea, stomach pain, aches or cramps that stay longer, and uncharacteristic weight loss are all common signs. Increased disease incidence is anticipated to drive market expansion. Demand for direct-to-consumer laboratory testing has increased as the healthcare sector moves away from physician-based lab testing. Modern direct-to-consumer laboratory testing techniques are essential for better monitoring and screening of pre-existing medical disorders and for boosting patient engagement. As technology develops, more and more test alternatives are becoming available. Because of this, consumers favour less expensive options for faecal occult blood testing. As a result, alternatives that are less expensive and yield more precise results are preferred. Also, change in consumer preferences in favour of less expensive alternatives could restrain market growth throughout the projection period.

By Product

  • Guaiac FOB Stool Test
  • Immuno-FOB Agglutination Test
  • Lateral Flow Immuno-FOB Test
  • Immuno-FOB ELISA Test

By End User

  • Hospitals
  • Clinical Diagnostic Laboratories
  • Physicians' Office Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to widespread consumer knowledge and a quickly rising market for technologically advanced faecal occult blood test kits, North America has dominated the global faecal occult testing industry. Because of the high adoption rate of point-of-care testing kits, the U.S. dominates the North American market for faecal occult testing. Also, according to end-user, globally the clinical diagnostic laboratories segment registered a 17.9% revenue share in 2022, trailing is the hospital segment, which holds a 59.8% revenue share.

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the Fecal Occult Market by product, by end-user, by region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Fecal Occult Testing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Fecal Occult Testing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Fecal Occult Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Fecal Occult Testing Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Guaiac FOB Stool Test
        2. Immuno-FOB Agglutination Test
        3. Lateral Flow Immuno-FOB Test
        4. Immuno-FOB ELISA Test

  • 8.   Global Fecal Occult Testing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinical Diagnostic Laboratories
        3. Physicians' Office Laboratories

  • 9.   North America Fecal Occult Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Fecal Occult Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Fecal Occult Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Fecal Occult Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Fecal Occult Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Quidel Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. EIKEN CHEMICAL CO., LTD.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Epigenomics AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Beckman Coulter, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Abbott Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Biohit Oyj.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Polymedco CDP, LLC
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Quest Diagnostics Incorporated
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Randox Laboratories Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. EDP Biotech
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients